July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Dipeptidyl deptidase-IV inhibition by sitagliptin slows down retinal neurodegeneration in rd10 mice retinas.
Author Affiliations & Notes
  • Oksana Kutsyr
    Physiology, Genetics and Microbiology, University of Alicante, Alicante, Alicante, Spain
  • Blanca Arango-Gonzalez
    Centre for Ophthalmology, University Eye Hospital Tübingen, Tübingen, Tübingen, Germany
  • Laura Fernandez-Sanchez
    Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Alicante, Spain
  • Victoria Maneu
    Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Alicante, Spain
  • Pedro Lax
    Physiology, Genetics and Microbiology, University of Alicante, Alicante, Alicante, Spain
  • Antonio F Ambrosio
    Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Coimbra, Portugal
  • Marius Ueffing
    Centre for Ophthalmology, University Eye Hospital Tübingen, Tübingen, Tübingen, Germany
  • Nicolas Cuenca
    Physiology, Genetics and Microbiology, University of Alicante, Alicante, Alicante, Spain
  • Footnotes
    Commercial Relationships   Oksana Kutsyr, None; Blanca Arango-Gonzalez, None; Laura Fernandez-Sanchez, None; Victoria Maneu, None; Pedro Lax, None; Antonio Ambrosio, None; Marius Ueffing, None; Nicolas Cuenca, None
  • Footnotes
    Support  MINECO-FEDER BFU2015-67139-R, RETICS-FEDER RD16/0008/0016, Prometeo 2016/158, ACIF/2016/055.
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4879. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Oksana Kutsyr, Blanca Arango-Gonzalez, Laura Fernandez-Sanchez, Victoria Maneu, Pedro Lax, Antonio F Ambrosio, Marius Ueffing, Nicolas Cuenca; Dipeptidyl deptidase-IV inhibition by sitagliptin slows down retinal neurodegeneration in rd10 mice retinas.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4879. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinitis Pigmentosa (RP) is an inherited retinal degenerative disease characterized by a progressive loss of structure and function of photoreceptors and retinal pigmented epithelium. The disease courses with oxidative stress, inflammation and apoptosis processes. Sitagliptin is a dipeptidyl peptidase-IV inhibitor that has demonstrated neuroprotective effects in mouse models of diabetes. This work aimed to evaluate the possible neuroprotective effect of sitagliptin in RP.

Methods : Rd10 mice were used as a model of RP. The animals were treated orally with sitagliptin (10 mg/Kg/day) or vehicle (PBS). Electroretinography (ERG), optomotor test and vertical retinal cryostat sections stained with hematoxylin or immunohistochemistry were used to evaluate the function and morphology of the retina. Secondly, retinal organotypic cultures treated with 0.1 μM of sitagliptin were performed to determine the effect and the action pathways of sitagliptin directly on the retina, discarding systemic influences. These retinas were analyzed to measure the percentage of TUNEL-positive cells and quantify changes in cytochrome c, CREB, pCREB, and CHOP, proteins involved in sitagliptin action pathway, using western blot.

Results : Sitagliptin administration improved retinal function in rd10 mice, displaying significantly higher amplitudes in a- and b-waves (p<0.001 both), as well as higher visual acuity (p<0.001). These functional findings correlated with a raised number of photoreceptor rows found in sitagliptin treated animals (p<0.05 in all measured points). Better-preserved photoreceptor outer and inner segments as well as well-defined axon terminals were observed in treated animals. Furthermore, presynaptic and postsynaptic elements, and synaptic contacts between photoreceptors and bipolar or horizontal cells were preserved. On the other hand, retinal organotypic cultures treated with sitagliptin showed 35% less TUNEL-positive cells (p<0.01) and western blot analysis revealed less cytochrome c and higher CREB and pCREB expression.

Conclusions : Sitagliptin treatment delayed retinal degeneration either by systemic administration or by local retinal treatment ameliorating function loss and photoreceptor cell survival, and preserving the cell morphology and the connectivity between the cells in the retina.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×